House Commerce Health Subcommittee Generics Hearing Planned For June
This article was originally published in The Tan Sheet
Executive Summary
The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.
You may also be interested in...
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Pediatric Study Incentive Could Be Tax Credit, Not Exclusivity - Rep. Pallone
Tax credits or reimbursements may be alternative incentives to encourage manufacturers to conduct pediatric studies, Rep. Frank Pallone (D-N.J.) suggested during a House Energy & Commerce/Health Subcommittee hearing May 3.
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.